Jakavi Tablets 5mg (Ruxolitinib phosphate) from Novartis Pharma, YJ code 4291034F1029 (5mg 1 tablet), is used to treat certain blood disorders such as myelofibrosis and polycythemia vera. It is also indicated for graft-versus-host disease in adults and children 12 years of age and older.
Jakavi Tablets 5mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
